These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 16085216)
1. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216 [TBL] [Abstract][Full Text] [Related]
2. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187 [TBL] [Abstract][Full Text] [Related]
3. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis. Sugiyama K; Mukae H; Ishii H; Kakugawa T; Ishimoto H; Nakayama S; Shirai R; Fujii T; Mizuta Y; Kohno S Respirology; 2006 Nov; 11(6):708-14. PubMed ID: 17052298 [TBL] [Abstract][Full Text] [Related]
4. Angiostatic versus angiogenic chemokines in IPF and EAA. Martina S; Martina V; Monika M; Jan P; Libor K; Ilja S Respir Med; 2009 Nov; 103(11):1651-6. PubMed ID: 19535235 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S Respiration; 2005; 72(1):39-45. PubMed ID: 15753633 [TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539 [TBL] [Abstract][Full Text] [Related]
7. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213 [TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745 [TBL] [Abstract][Full Text] [Related]
9. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis. Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097 [TBL] [Abstract][Full Text] [Related]
10. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases. Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954 [TBL] [Abstract][Full Text] [Related]
12. Expression of chemokine receptors CXCR3 and CCR4 in lymphocytes of idiopathic nonspecific interstitial pneumonia. Yoshinouchi T; Naniwa T; Shimizu S; Ohtsuki Y; Fujita J; Sato S; Eimoto T; Ueda R Respir Med; 2007 Jun; 101(6):1258-64. PubMed ID: 17137778 [TBL] [Abstract][Full Text] [Related]
13. Anti-endothelial cell antibodies in patients with interstitial lung diseases. Matsui T; Inui N; Suda T; Chida K Respir Med; 2008 Jan; 102(1):128-33. PubMed ID: 17851060 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis]. Xiao L; Li ZH; Hou XM; Yu RJ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):686-8. PubMed ID: 14703444 [TBL] [Abstract][Full Text] [Related]
15. High serum concentrations of autoantibodies to HSP47 in nonspecific interstitial pneumonia compared with idiopathic pulmonary fibrosis. Kakugawa T; Yokota S; Mukae H; Kubota H; Sakamoto N; Mizunoe S; Matsuoka Y; Kadota J; Fujii N; Nagata K; Kohno S BMC Pulm Med; 2008 Nov; 8():23. PubMed ID: 18983650 [TBL] [Abstract][Full Text] [Related]
17. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791 [TBL] [Abstract][Full Text] [Related]
18. [Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis]. Li JZ; Li ZH; Kang J; Hou XM; Yu RJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):378-80. PubMed ID: 15256084 [TBL] [Abstract][Full Text] [Related]
19. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis. Inage M; Nakamura H; Kato S; Saito H; Abe S; Hino T; Tomoike H Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422 [TBL] [Abstract][Full Text] [Related]
20. [Changes of the activities of ET-1 in the serum and BALF of ILD patients and their clinical significance]. Li Z; Xia S; Hou X Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jul; 22(7):411-3. PubMed ID: 11775813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]